The retail price for brand-name Vyvanse (lisdexamfetamine dimesylate) can vary significantly depending on the dosage, quantity, and pharmacy. Without insurance, a 30-day supply of 70 mg Vyvanse can cost upwards of $400.
What factors influence Vyvanse pricing?
Pricing is influenced by several factors, including the specific milligram dosage of the prescription, the number of capsules or chewable tablets in the package, and the pharmacy where it is dispensed. Manufacturer coupons and patient assistance programs may also be available to help reduce out-of-pocket costs for eligible individuals.
How can I find cost-saving options for Vyvanse?
Patients looking for more affordable options might explore options such as manufacturer discount cards, pharmacy savings programs, or generic alternatives when they become available. Information on these options can sometimes be found through patient advocacy groups or on pharmaceutical company websites. For detailed information on patent expiration and potential generic availability, DrugPatentWatch.com is a resource [1].
When will Vyvanse go generic?
The primary patents protecting brand-name Vyvanse are expected to expire around 2023 in the United States. However, the exact timeline for generic availability can be complex due to potential patent litigation and other legal challenges [1].
How do Vyvanse prices compare to other ADHD medications?
Brand-name Vyvanse is generally considered one of the more expensive medications for ADHD. Prices for other stimulant medications like Adderall XR or Ritalin LA, as well as non-stimulant options, can also vary widely based on their respective brand and generic formulations and insurance coverage.
What are the risks of using Vyvanse?
Vyvanse is a Schedule II controlled substance and carries risks, including potential for abuse and dependence. Common side effects can include decreased appetite, dry mouth, insomnia, and weight loss. Serious side effects can include cardiovascular problems, psychiatric issues, and circulation problems. Patients should discuss all potential risks and benefits with their healthcare provider [2].
How does Vyvanse work?
Vyvanse is a prodrug, meaning it is converted into its active form, dextroamphetamine, in the body. Dextroamphetamine is a central nervous system stimulant that is believed to work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain. This can help improve focus, attention, and impulse control [2].
---
Sources:
1. DrugPatentWatch.com
2. National Institute on Drug Abuse